Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry

BACKGROUND: Data on fibrinolytic therapy use for ST-segment elevation myocardial infarction (STEMI) and long-term clinical outcomes in developing countries are limited. We aimed to investigate the management and 2-year mortality of fibrinolytic-treated patients in China. METHODS: A total of 19,112 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chao, Li, Ling, Wang, Shuqing, Zeng, Jianping, Yang, Jingang, Xu, Haiyan, Zhao, Yanyan, Wang, Yang, Li, Wei, Jin, Chen, Gao, Xiaojin, Yang, Yuejin, Qiao, Shubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948459/
https://www.ncbi.nlm.nih.gov/pubmed/36814182
http://dx.doi.org/10.1186/s12872-023-03105-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948459/
https://www.ncbi.nlm.nih.gov/pubmed/36814182
http://dx.doi.org/10.1186/s12872-023-03105-1

Ejemplares similares